Best Adrenal tumor Doctors Worldwide — TOP 85

Dr. Ilker Tinay leads the urology department at Anadolu Medical Center, specializing in urological cancers with minimally invasive techniques.

• Urological oncologist with expertise in adrenal tumor treatment
• Performs minimal invasive surgery for precise tumor removal
• Executive board member of the Association of Urooncology
• Fluent in English and German for international patients
• Secretary of the Bladder Tumours Research Group

Dr. Bulent Karagoz is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in immunotherapy and targeted therapies for sarcoma, lymphoma, and lung cancer. Dr. Karagoz provides treatment at a facility affiliated with the prestigious Johns Hopkins Hospital.

• Authored over 40 research publications focusing on tumor biology and immunology.
• Former Head of Internal Diseases at Istanbul Okan University Faculty of Medicine.
• Held leadership roles in medical oncology at GATA Haydarpasa Training Hospital.
• Member of the Turkish Medical Oncology Association and European Head and Neck Society.

Dr. Banu Atalar is a professor and radiation oncologist at Anadolu Medical Center. She is an Honorary Fellow of the American College of Radiology (H.FACR). She completed a clinical research fellowship in stereotactic radiosurgery at Stanford University. Stereotactic radiosurgery and MR-guided adaptive SRS make up 75% of her clinical practice.

• President of the Turkish Society for Radiation Oncology.
• Chair of the ESTRO National Societies Committee.
• Recipient of the ASCO International Development and Education Award.
• Author of over 70 international peer-reviewed publications.

One of Austria's most prominent oncologists, Prof. Zielinski has shaped modern cancer treatment over four decades. He now leads Wiener Privatklinik's International Oncology Center.

• Led Austria's largest oncology department as Head at Vienna General Hospital
• Founded and directed the Comprehensive Cancer Center Vienna (CCC)
• Pioneers individualized cancer therapy and immuno-oncology research
• Published extensively in leading journals on new treatment development
• Former President of the Central European Cooperative Oncology Group

Dr. Huseyin Baloglu is a pathologist at Anadolu Medical Center in Turkey. He leads liquid biopsy and precision oncology services. Dr. Baloglu holds a patent for molecular diagnostics in thyroid cancer treatment. He completed training at Albert Einstein College of Medicine and Heidelberg University.

• Authored over 600 peer-reviewed publications in molecular and surgical pathology.
• Specializes in tumor biopsy, immunohistochemistry, and genetic mutation testing.
• Treats complex oncological cases, including glioblastoma and rare sarcomas.
• Works at Anadolu Medical Center, a facility affiliated with Johns Hopkins Medicine.

Prof. Merimsky heads the Unit of Soft Tissue and Bone Oncology at Sourasky Medical Center, specializing in rare and complex tumors.

• Over 41 years of experience of experience in oncology, with a focus on sarcomas
• Fellowship-trained at Institut Gustave Roussy in Paris for sarcoma treatment
• Member of ESMO Faculty for Soft Tissue and Bone Sarcoma
• Conducts extensive research in tumor immunology and targeted therapies

Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.

Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.

Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Leading certified expert by Intuitive Surgical – Dr. Tvaruzek has performed over 3,500 robotic surgeries at St. Zdislava Hospital.

• Specializes in robotic surgery for adrenal tumors
• Heads the Center of Robotic Surgery in Czech Republic
• Member of Association of Aesthetic Medicine and Bariatric Surgery
• Uses Da Vinci robotic system for precise tumor removal

Dr. Onder Surgit is a professor of general surgery at Optimed International Hospital. He is a surgical instructor at the Advanced Medical Technologies Training Center (ITEM). Dr. Surgit treats cancer, obesity, and complex gastrointestinal conditions. He applies laparoscopic techniques for weight loss and tumor removal.

• Specializes in bariatric surgery including gastric sleeve, bypass, and balloon procedures.
• Performs oncological surgeries for breast, lung, stomach, and colon cancer.
• Served as a faculty member at Turgut Ozal and Atilim Universities.
• Works at AACI-accredited Optimed International Hospital in Tekirdag, Turkey.

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Professor Sezer Sağlam specializes in gastrointestinal oncology with a focus on adrenal tumors at Gayrettepe Florence Nightingale Hospital.

• Over 27 years of experience of experience in medical oncology
• Fellowship-trained at Istanbul University's Medical Faculty
• Member of ESMO, ASCO, and ENET societies
• Previously trained in hemodialysis at Cerrahpasa Medical Faculty

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Dr. Altay Aliyev specializes in adrenal tumor treatment with a focus on targeted therapies and immunotherapy at Liv Bona Dea Hospital Baku.

• Trained at Istanbul University and Cleveland Clinic
• Expert in cytotoxic chemotherapy and hormonotherapy
• Published multiple research papers on cancer treatment
• Member of prestigious medical oncology subdivisions

Dr. Osama Abdel Mohimen Mohamed leads the Hematology Unit at Shefaa Al Orman Oncology Hospital. He treats complex blood cancers, including leukemia, lymphoma, and myeloma. Dr. Mohamed is a member of the European Society for Medical Oncology. He also holds memberships in the American Society of Hematology and ASBMT.

• Specializes in chemotherapy, immunotherapy, and bone marrow transplantation.
• Manages aggressive acute leukemia and chronic blood disorders.
• Treats complications arising from various solid tumors.
• Works at an ESMO-accredited center that handles 6,000 patients annually.

Prof. Sefik Igdem specializes in radiation oncology at Gayrettepe Florence Nightingale Hospital, using advanced technologies like Truebeam Stx and Halcyons for precise treatments.

• Professor at T.R. Demiroğlu Bilim University
• Specializes in head and neck cancers
• Expert in conformal radiotherapy techniques
• Trained at Istanbul University Cerrahpaşa Faculty of Medicine

Dr. Yuri Goldes is the Deputy Director of General Surgery at Sheba Medical Center. He pioneered some of Israel’s first robotic resections for stomach and pancreatic cancers. Forbes Israel named him among the nation’s best gastrointestinal surgeons. In 2019, he received the Best Doctor of the Year award from the Israeli Ministry of Health.

• Specializes in robotic and laparoscopic surgery for pancreatic, gastric, and esophageal cancers.
• Performs minimally invasive Whipple procedures, one of the most complex abdominal operations.
• Treats benign conditions including diaphragmatic hernia, achalasia, GERD, and gallbladder disease.
• Works at Sheba Medical Center, ranked among the Top 10 hospitals worldwide by Newsweek.

Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).

He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.

Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.

Dr. Erdem Turemen is an endocrinologist at Anadolu Medical Center in Istanbul. He has authored over 25 national and international medical publications. Dr. Turemen treats diabetes, obesity, and thyroid disorders. He also manages complex diseases of the pituitary and adrenal glands.

• Specializes in Type 1 and Type 2 diabetes management.
• Treats endocrine-related cancers including thyroid and adrenal tumors.
• Performs thyroid biopsies and subtotal thyroidectomy procedures.
• Works at Anadolu Medical Center, a Top 10 global hospital by MTQUA.

Mustafa Solak specializes in adrenal tumors with fellowship training at Hacettepe University Cancer Institute – one of Turkey's leading oncology centers.

• Trained at The University of Texas MD Anderson Cancer Center
• Experienced in complex endocrine oncology cases
• Works at Hisar Hospital Intercontinental's oncology department

Professor Yesim Yildirim specializes in cancer immunotherapy and targeted therapies, with over 80 international publications and co-authorship in major oncology handbooks.

• Member of European Society of Medical Oncology (ESMO)
• Professor at Halic University, combining clinical practice with academic leadership
• Specializes in breast, gastrointestinal, and lung cancers
• Trained at prestigious institutions including Mount Vernon Cancer Center in London